Hammad Muhammad, Tashtoush Mohammad Mousa, El Faki El Mutasim Ahmed, Hajaj Marwa Yousif, Ahmed Saima Saeed, Darwish Amal Ahmed
Al Ain Hospital, Al Ain, United Arab Emirates.
J Pharm Policy Pract. 2023 Mar 2;16(1):36. doi: 10.1186/s40545-023-00542-3.
The recent SARS-CoV-2 pandemic has resulted in significant morbidity and mortality worldwide. The healthcare systems, including pharmacies, faced unique challenges, such as managing an overwhelming patient influx, clinical workforce management, transitioning to remote or online work, medication procurement and several others. The purpose of this study is to describe our hospital pharmacy's experience dealing with the COVID-19 pandemic and to present solutions to the challenges that arose.
We retrospectively reviewed and consolidated strategies, interventions, and solutions that were implemented by our pharmaceutical institute in response to the challenges that arose during the COVID-19 pandemic. The study period was from March 1 to September 30, 2020.
We reviewed and organized our hospital pharmacy response to the COVID-19 pandemic into different categories. In inpatient and outpatient satisfaction surveys, physicians and patients expressed a high level of satisfaction with pharmacy services. The close collaboration between the pharmacy team and other clinicians was demonstrated through the number of pharmacist interventions, participation in the COVID-19 guidelines reviews, involvement in local and international research, and innovative solutions to inpatient and outpatient pharmacy medication management challenges.
This study highlights the crucial role that our pharmacists and pharmaceutical institute played in ensuring continuity of care during the COVID-19 pandemic. We implemented several key initiatives, innovations, and collaborations with other clinical disciplines to successfully overcome the challenges faced.
近期的新型冠状病毒肺炎大流行已在全球范围内导致了严重的发病率和死亡率。包括药房在内的医疗保健系统面临着独特的挑战,例如应对大量患者涌入、临床劳动力管理、向远程或在线工作过渡、药品采购以及其他一些挑战。本研究的目的是描述我们医院药房应对新型冠状病毒肺炎大流行的经验,并提出应对所出现挑战的解决方案。
我们回顾并整合了我们的制药机构为应对新型冠状病毒肺炎大流行期间出现的挑战而实施的策略、干预措施和解决方案。研究期间为2020年3月1日至9月30日。
我们将医院药房对新型冠状病毒肺炎大流行的应对措施进行了回顾并分类整理。在住院患者和门诊患者满意度调查中,医生和患者对药房服务表示高度满意。药房团队与其他临床医生之间的密切合作体现在药剂师干预的次数、参与新型冠状病毒肺炎指南审查、参与本地和国际研究以及针对住院和门诊药房药物管理挑战的创新解决方案等方面。
本研究突出了我们的药剂师和制药机构在确保新型冠状病毒肺炎大流行期间医疗服务连续性方面所发挥的关键作用。我们实施了多项关键举措、创新措施,并与其他临床学科开展了合作,以成功克服所面临的挑战。